Official UK procurement notice
IPTACOPAN HYDROCHLORIDE MONOHYDRATE 200MG CAPSULES, 56 capsules, pack
Authority: Belfast Health & Social Care Trust (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£400,000published award · exc. VAT
Awarded 15 May 2025no call for competition
Awarded to NOVARTIS PHARMACEUTICALS UK LIMITED
What is being bought
Published requirement descriptionProcurement of IPTACOPAN HYDROCHLORIDE MONOHYDRATE 200MG CAPSULES, 56 capsules, pack
The lotProcurement structure
single lot · no lot value publishedLot #1Lot 1Awarded
33600000 Pharmaceutical products
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award — no call for competition
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 20 Apr 2026, 14:08 BST
- Last source update
- 20 Apr 2026, 14:08 BST
- Authority reference
DACPM2025-19- Latest notice
- Contract termination notice (UK11)
- Delivery area
- Official registry OCID
ocds-h6vhtk-051404
- Why no open competition
- Single Suppliers Intellectual Property Exclusive Rights
- Published justification
- These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.
How it was run
- Submission deadline
- —
Timeline
2 published dates · Europe/London- Standstill ends27 May 2025, 23:59 BST
- Notice published159 days ago20 Apr 2026, 14:08 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics — not a forecastAwards 1
Awarded value £400,0001 award exc. VAT
Contracts signed 1latest 3 Jun 2025
| Awarded to | Value | Date | Status |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITED17 Jun 2025 — 30 Jun 2027 | £400,000 | 15 May 2025 | Awarded |
Contracts
IPTACOPAN HYDROCHLORIDE MONOHYDRATE 200MG CAPSULES, 56 capsules, pack · NOVARTIS PHARMACEUTICALS UK LIMITED
- Signed
- 3 Jun 2025
- Value
- £400,000
- Period
- 3 Jun 2025 — 30 Jun 2027
- Status
- terminated
- Final value
- £400,000
- Termination
- other
No agreed KPIs: Contract value is below the relevant threshold for setting Key performance indicators
Notice history
8 events · 4 releases on Find a Tender · since 15 May 2025- Contract termination notice published20 Apr 2026, 14:08 BSTUK11
- Status changed20 Apr 2026, 14:08 BST
- Procurement method changed20 Apr 2026, 14:08 BST
- Buyer details updated20 Apr 2026, 14:08 BST
- Contract signature expected16 Jun 2025, 23:59 BSTscheduled
- Contract details notice published6 Jun 2025, 13:53 BSTUK7
- Contract award notice published15 May 2025, 10:53 BSTUK6
- Transparency notice published15 May 2025, 10:42 BSTUK5
Routine re-releases (4)
- 2025-05: 1 release · 15 May 2025
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- NOVARTIS PHARMACEUTICALS UK LIMITEDAwarded supplier
Official documents & specifications (5)
Official links; attachments are not copiedTender pack and attachments
- Conflict of interest declarationNot published
Notices published for this procedure
- Contract termination notice Contract termination notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender